Related by context. All words. (Click for frequent words.) 61 Natixis Bleichroeder analyst 59 analyst Jim Reddoch 58 Tenthoff 58 Moussatos 58 Joel Sendek 58 Krensavage 57 Eric Ende 57 BernsteinResearch 57 analyst Jim Birchenough 57 analyst Cory Kasimov 57 PiperJaffray analyst 56 Pantginis 56 Sam Fazeli 56 Geoff Meacham 56 Geoffrey Meacham 56 Annabel Samimy 55 Yaron Werber 55 Dr. Jim Birchenough 55 analyst Jonathan Aschoff 55 analyst Geoffrey Meacham 55 analyst Mark Schoenebaum 55 Roopesh Patel 55 Andreas Theisen 54 Geoffrey Porges 54 analyst Gbola Amusa 54 Geoff Porges 54 Jason Kolbert 54 Denhoy 54 analyst Geoffrey Porges 54 analyst Liana Moussatos 54 Mark Schoenebaum 54 Liisa Bayko 54 Kochnover 53 analyst Jami Rubin 53 Monane 53 Molowa 53 Jon LeCroy 53 Ronny Gal 53 Funtleyder 53 analyst Randall Stanicky 53 Olav Zilian 52 Cory Kasimov 52 Piper Jaffray PJC 52 Joshua Schimmer 52 Mike Krensavage 52 McCamant 52 Jim Reddoch 52 analyst Glenn Novarro 52 Jon Lecroy 52 Coffina 52 Kevin Scotcher 52 Edward Tenthoff 52 Laboratories Rahway NJ 52 Simos Simeonidis 52 analyst Yaron Werber 51 David Amsellem 51 analyst Seamus Fernandez 51 Joseph Pantginis 51 Bret Holley 51 Birchenough 51 reaffirmed Neutral 51 analyst Simos Simeonidis 51 Steven Harr 51 analyst Bruce Nudell 51 Plachetka 51 Zekauskas 51 Biomarin 51 analyst Ken Trbovich 51 Leerink 51 Jerry Doctrow 51 Trevor Polischuk 51 Bapty 51 Ian Somaiya 51 Gbola Amusa 50 reaffirmed Outperform rating 50 Leerink Swan 50 Eric Siemers 50 Ulrich Huwald 50 Alexandra Hauber 50 Landsbanki Kepler analyst 50 Stanicky 50 Akhtar Samad 50 Bert Hazlett 50 analyst Lawrence Keusch 50 Genentech Herceptin 50 Bugatch 50 Savvas Neophytou 50 Forest Labs FRX 50 Merck boceprevir 50 Saftlas 50 Natexis Bleichroeder analyst 50 analyst Ross Muken 50 told BioWorld Today 50 Jami Rubin 50 Jason Kantor 49 David Molowa 49 Switzerland Serono SA 49 analyst Amit Hazan 49 analyst Mark Monane 49 Chris Shibutani 49 Sepracor SEPR 49 Jim Birchenough 49 analyst George Grofik 49 Grofik 49 Quynh Pham 49 Badishkanian 49 analyst Glenn Reicin 49 Matt Miksic 49 Mark Monane 49 Reddoch 49 analyst Junaid Husain 49 Gudme Raaschou 49 Helene Wolk 49 Adventrx 49 Affymax AFFY 49 analyst Konrad Becker 49 Drakeman 49 Vontobel analyst 49 analyst Larry Biegelsen 49 analyst Sapna Srivastava 49 analyst Navid Malik 49 Suji De Silva 49 Seamus Fernandez 49 Randall Stanicky 49 Dominic Valder 49 Carl Seiden 48 William F. Tanona 48 Redburn Partners 48 Stephen Tusa 48 Holger Blum 48 Napodano 48 Sav Neophytou 48 Suntrust Robinson Humphrey 48 JoAnne Feeney 48 Mabthera 48 FBR Capital Markets FBCM 48 Recentin 48 Ziopharm 48 midstage clinical 48 Siegall 48 Gary Nachman 48 Curagen 48 ImmunoGen IMGN 48 Leerink Swan analyst 48 spokeswoman Naomi Aoki 48 analyst Antony Broadbent 48 analyst Gregory Badishkanian 48 Zocor Zetia 48 Bruce Cranna 48 Stacy Rasgon 48 Creditsights 48 Seattle Genetics SGEN 48 Paul Cuddon 48 WR Hambrecht analyst 48 PiperJaffray 48 Maraganore 48 Jonathan Aschoff 48 analyst Alexandra Hauber 47 Simeonidis 47 Gilead GILD 47 P. Heymann 47 Biegelsen 47 Navid Malik 47 Damien Conover 47 Xenoport 47 Gilead Sciences nasdaq GILD 47 analyst Kimberly Greenberger 47 WestLB Panmure 47 analyst Dinesh Moorjani 47 Biogen multiple sclerosis 47 Rajesh Ghai 47 Claude Zehnder 47 Larry Biegelsen 47 Campagnino 47 Lawrence Keusch 47 Justin Hott 47 Groschke 47 Idenix Pharmaceuticals 47 Panmure analyst 47 Porges 47 analyst Mitch Kummetz 47 Panmure Gordon stockbrokers 47 Jason Gurda 47 Ingrid Ebeling 47 Paul Mansky 47 Kepler Equities analyst 47 analyst Robert Cihra 47 Vontobel analyst Andrew 47 anlayst 47 Krystexxa 47 Muntner 47 Bruce Nudell 47 analyst Hari Sambasivam 47 Medivation Inc 47 analyst Amit Bhalla 47 Pablo Zuanic 47 DepoMed 47 spokeswoman Caroline Pecquet 47 Eric Coldwell 47 JMP Securities analyst 47 analyst Louis Miscioscia 47 Versant Partners analyst 47 analyst Frank Mitsch 47 analyst Fabrizio Croce 47 Darkatsh 47 Amylin Eli Lilly 47 Lisnic 47 Kin Ho 46 Ken Cacciatore 46 Martin Possienke 46 Edelstone 46 Andrew Vaino 46 Karl Heinz Scheunemann 46 Mosesmann 46 Scott Geels 46 Carla Antunes da Silva 46 Michael Krensavage 46 Steven Burakoff 46 analyst Robert Drbul 46 DiFucci 46 MyVax 46 broker Seymour Pierce 46 Geoff Ruddell 46 analyst Sanjay Vidyarthi 46 Wolfgang Renner 46 George Grofik 46 ONXX 46 analyst Elemer Piros 46 Aschoff 46 Birgit Kulhoff 46 Cantor Fitzgerald reiterates 46 ABX EGF 46 Viropharma 46 Kenji Masuzoe 46 B. Nemeroff 46 analyst Luca Solca 46 VRTX 46 Petercam analyst 46 analyst Albert Savastano 46 Finncap 46 Analyst Cody Acree 46 Plovanic 46 Exane BNP 46 ThinkEquity analyst 46 Advate 46 Syncria 46 BernsteinResearch analyst 46 RW Baird analyst 46 analyst Mark Lipacis 46 Sanganeria 46 ANALYST TAKE Stifel Nicolaus 46 Kepler Capital Markets 46 Oncogenex 46 Masdea 46 Ariad Pharmaceuticals 46 Tanona 46 Neely Tamminga 46 Zolopa 46 Cannacord Adams 46 Colazal 46 Dr. LaMattina 46 Schondelmeyer 46 Sackner Bernstein 46 James Manuso 46 Niedel 45 BiolineRX 45 Lebwohl 45 Raj Denhoy 45 Equinet 45 Raafat Fahim 45 analyst Jeffrey Zekauskas 45 Aaron Reames 45 Constantine Davides 45 United Therapeutics UTHR 45 Mutascio 45 Orencia 45 Silversteyn 45 analyst Jeremy Batstone 45 Robert Spanheimer 45 Biogen Nasdaq BIIB 45 Edwin Hemwall 45 Kash Rangan 45 ImClone Erbitux 45 Barrie Cornes analyst 45 Urdal 45 Leckow 45 Boorady 45 reaffirmed Market Perform 45 Equal Weight rating 45 Collyn Gilbert 45 Drbul 45 Tore Svanberg 45 brokerage Numis 45 analyst Nicholas Heymann 45 Wagonfeld 45 Zolidis 45 Daniele Antonucci 45 Ricky Goldwasser 45 Edward Najarian 45 Dr. Yaron Werber 45 Tamminga 45 ANALYST TAKE Morgan Stanley 45 Swiss brokerage Helvea 45 Sipkin 45 Pyykkonen 45 Deborah Weinswig 45 Kristine Koerber 45 Brian Bapty 45 analyst Stephen Tusa 45 Elan Tysabri 45 Mark Swartzberg 45 analyst Dara Mohsenian 45 Michael Masdea 45 Blackmont analyst 45 Neurosearch 45 Kathryn Huberty 45 John DiFucci 45 Joe Pantginis 45 Graseck 45 Orbimed 45 Isis Pharma 45 Armando Anido 45 analyst Jason Napodano 45 W. Ruttenbur 45 S. Drbul 45 Barry Labinger 45 Lipworth 45 Leerink Swann analyst 45 Kaitin 45 Canvaxin 45 analyst Sterling Auty 45 Keay Nakae 45 Lars Ekman 45 Bank Vontobel analyst 45 spokesman Tony Plohoros 44 Michael Leuchten 44 Effexor antidepressant 44 analyst Anthony Chukumba 44 Seymour Pierce analyst 44 Velcade bortezomib 44 Corlux 44 NASDAQ ANDS 44 analyst Randal Konik 44 analyst Michael Bruynesteyn 44 Aloprim 44 McKhann 44 Maneaty 44 Shiv Kapoor 44 analyst Pablo Zuanic 44 analyst William Pecoriello 44 analyst Robert Campagnino 44 CE Unterberg 44 Navdeep Jaikaria 44 Erlen 44 analyst Gurinder Kalra 44 analyst Hans Mosesmann 44 Achillion Pharmaceuticals 44 analyst Tore Svanberg 44 Myriad Genetics MYGN 44 Squali 44 Landsbanki Kepler 44 Zuanic 44 Douglas Anmuth 44 Credit Sights 44 Claude Camire 44 Millennium Velcade 44 analyst Phillip Nalbone 44 analyst Bruce Cranna 44 ThinkPanmure 44 analyst Ghansham Panjabi 44 Sara Michelmore 44 NuVasive NUVA 44 Terreson 44 analyst Maged Shenouda 44 analyst Shebly Seyrafi 44 Julian Heslop 44 analyst Silke Stegemann 44 Jefferies JEF 44 MKM Partners analyst 44 Neutral Weight 44 Dolat Capital Market 44 Grasher 44 Dr. Joshua Schimmer 44 analyst Gregory Melich 44 Kieburtz 44 analyst Dan Wantrobski 44 Poordad 44 Betsy Graseck 44 Jeffrey Blaeser 44 Broadpoint Amtech 44 Comfort #-#-# ccomfort@dresources.com 44 Analyst Sid Parakh 44 J. Zekauskas 44 Hugh Guy Lorriman 44 Lipacis 44 broker Panmure Gordon 44 Suresh Balaraman 44 Fabrizio Croce 44 analyst Joseph Greff 44 IG HCR ;) CO 44 Sarah Friar 44 Luke Folta 44 spokesman Jose Juves 44 Joseph Amaturo 44 Bank Degroof analyst 44 Janedis 44 Allan Monks 44 Elmar Schnee 44 Optimer Pharmaceuticals 44 Capstone Investments 44 Manoj Garg 44 James Janesky 44 Xenoport Inc. 44 Luuk van Beek 44 David Hochstim 44 Genentech Raptiva 44 Nollenberger Capital 44 Dale Pfost 44 Greg Geissman 44 analyst Nigel Dally 44 Reicin 44 Singer Capital Markets 44 Reiterates Hold 44 Scott Krasik 44 HealthCor 44 Glenn Novarro 44 Cliggott 44 Walravens 44 Jesse Tortora 44 P. Klinefelter 44 Claudia Shank Hueston 44 Ehud Gelblum 44 Charles Boorady 44 analyst Emme Kozloff 44 analyst Ali Dibadj 44 drug Treanda 44 Steven Winoker 44 Altium Securities analyst 44 Zonszein 44 Simponi golimumab 44 analyst Tim Savageaux 44 Bhavin Shah 44 Sid Parakh analyst 43 analyst Elizabeth Osur 43 Piper Jaffray nyse PJC 43 Ed Groshans 43 Rhyee 43 Tesofensine 43 Lawrence Biegelsen 43 Jeff Klinefelter 43 Sanford Bernstein analyst 43 Jeffrey Frelick 43 Menzler 43 Adam Barkstrom 43 Christopher Hogbin 43 Liana Moussatos 43 Alnylam Nasdaq ALNY 43 Christopher Danely 43 Piper Jaffrey 43 Schwab SoundView 43 analyst Julio Quinteros 43 Rehaut 43 FastMarkets 43 Danely 43 BGB Securities 43 Dr. McHutchison 43 Shedlarz 43 Bonte Friedheim 43 analyst Peter Nesvold 43 Thom Gunderson 43 analyst Michael Exstein 43 AMAG Pharma 43 Francescone 43 Heinbockel 43 Panmure Gordon analyst 43 Andrew Gollan 43 Feinseth 43 ANALYST TAKE Credit Suisse 43 Kugele 43 analyst Alex Gauna 43 Khorsand 43 Darren Aftahi 43 analyst Raghu Hariharan 43 Narachi 43 analyst Jonathan Schildkraut 43 HC Wainwright 43 Jeremy Sussman 43 Taunya Sell 43 analyst Walter Piecyk 43 Maintains Hold 43 analyst Kristine Koerber 43 Helvea analyst Olav Zilian 43 Charles Minervino 43 C. Bernstein 43 Rachael Rothman 43 muscle relaxant Amrix 43 Enyedy 43 McHutchison 43 Georges Gemayel 43 Celgene Revlimid 43 Novo Nordisk NOVOb.CO 43 Michael Turits 43 Louis Miscioscia 43 Punk Ziegel 43 Rule Breakers pick 43 economist Ted Wieseman 43 Randal Konik 43 Analyst Gene Munster 43 George Scangos 43 Biogen IDEC 43 Rhein Biotech GmbH 43 Helvea 43 Sanford Bernstein 43 Fernand de Boer 43 Sherri Scribner 43 Kepler Equities 43 Mott MedImmune 43 Zuerblis 43 Matthew Borsch 43 Mohsenian 43 Fanandakis 43 analyst Vijay Jayant 43 Aberman 43 Mark G. Foletta 43 Tom Gidley Kitchin 43 Amevive 43 Mark Astrachan 43 ANALYST TAKE JP Morgan 43 Rod Bourgeois 43 analyst Mario Mendonca 43 GILD GILD 43 Miehm 43 analyst Michael Rehaut 43 Keusch 43 Equinet analyst 43 Amylin Pharmaceuticals Nasdaq AMLN 43 Daviglus 43 Fetyko 43 analyst Rommel Dionisio 43 analyst Steven Wieczynski 43 BernsteinResearch analyst Dr. 43 Rilutek 43 Morten Singleton 43 Rummelt 43 Isaac Ro 43 Laegeler 43 macitentan 43 Serebruany 43 Merrion Stockbrokers 43 Avastin Herceptin 43 OGXI 43 analyst Mehdi Hosseini 43 Gelblum 42 Desmond Hellmann 42 Delafield Hambrecht 42 analyst Hisashi Moriyama 42 Tony Shiret 42 Degludec 42 Deane Dray 42 Helvea analyst 42 analyst Bijan Moazami 42 Moshe Katri 42 strategist Teun Draaisma 42 Zamvil 42 Greg Feehely 42 analyst Joseph Altobello 42 Reiterates Neutral Rating 42 ANALYST TAKE Goldman Sachs 42 Strategas Research 42 Pat Walravens 42 Analyst Toni Sacconaghi 42 Nasdaq GPRO announced 42 Thomas R. Wadewitz 42 Hussain Mooraj 42 Bob Drbul 42 AmTech analyst 42 T. Kron 42 analyst Donald Fandetti 42 Analyst Bill Pecoriello 42 Celgene Corp. 42 Glenn Reicin 42 Gene Munster Piper Jaffray 42 Resumes Coverage 42 Amgen Prolia 42 analyst Rebecca Runkle 42 Schimmer 42 Aderis 42 Gerard Klauer Mattison 42 Longbow Research analyst 42 Brandon Dobell 42 Borho 42 Hollenbeak 42 Grines 42 Richard Kwas 42 Kyran McLaughlin 42 Krishna Shankar 42 analyst Joshua Shanker 42 Tristan Gerra 42 Onyx Pharma 42 Promus stent 42 analyst Charles Grom 42 analyst Edwin Mok 42 Amsellem 42 Bruce Harting 42 Sector Outperformer 42 Fanapt iloperidone 42 Jean Philippe Bertschy 42 brokerage Helvea 42 PTK ZK 42 Rating Maintained 42 Oxigene 42 Kruszenski 42 BioMedTracker 42 Klaskow 42 Joanne Wuensch 42 ANALYST TAKE Lehman Brothers 42 analyst Sasa Zorovic 42 William Pecoriello 42 Polymeropoulos 42 David Turkaly 42 Atherogenics 42 Catalyst Biosciences 42 Craig Siegenthaler 42 analyst Raj Denhoy 42 MD DPhil 42 Drickamer 42 SoundView Technology 42 analyst Joanne Wuensch 42 Robert Lacoursiere 42 Favus Institutional Research 42 Jeffrey Holford 42 analyst Victor Bareno 42 Nick Bertolotti 42 THE SPARK Analyst 42 analyst Koya Tabata 42 Williams de Broe 42 John Calcagnini 42 Gets Downgraded 42 Borisy 42 Susan Katzke 42 Piper Jaffray analyst 42 analyst Kian Abouhossein 42 Virginia Genereux 42 Burkly 42 analyst Andrew Goodsall 42 Tyring 42 Myriad Genetics Nasdaq MYGN 42 Vance Edelson 42 FTN Midwest 42 Analysts Initiate Coverage 42 analyst Budd Bugatch 42 analyst Alexia Quadrani 42 Edwards Lifesciences EW 42 Lauren Cooks Levitan 42 analyst Bill Pecoriello 42 NV1FGF 42 Joel Fishbein 42 Zackfia 42 GE Omar Ishrak 42 Auxilium Pharma 42 Taranabant 42 Jeffrey Bencik 42 Mark Liinamaa 42 Underweight rating 42 Natexis Bleichroeder 42 Linenberg 42 Tao Levy 42 BAS ML 42 analyst Robert Koort 42 Camilo Lyon 42 Zadaxin 42 analyst Charles Boorady 42 ANALYST TAKE Citi 42 Eli Lilly LLY 42 analyst Ashwin Shirvaikar 42 Dabelea 42 analyst Mark Edelstone 42 Kalpesh Kapadia 42 analyst Bruce Harting 42 Mercks 42 analyst Patrick Walravens 42 Overweight rating 42 Krensavage Asset Management 42 Standpoint Research downgraded 42 Neibor 42 Kumpel 41 analyst Richard Repetto 41 Tobias Levkovich 41 Dhulsini de Zoysa 41 April Scee 41 Wendell Zerb 41 Alton Stump 41 Nathan Schneiderman 41 NASDAQ VRUS 41 Calcagnini 41 Christopher Mutascio 41 Ragen Mackenzie 41 NASDAQ INFI 41 Piper Jaffrey analyst 41 Auriga USA 41 Sterling Auty 41 Anmuth 41 Natixis Bleichroeder 41 analyst Cody Acree 41 Betsy Van Hees 41 Osol 41 MM Warburg analyst 41 Lazard Capital 41 Quadrani 41 Helfstein 41 Leerink Swann 41 A. Reitzes 41 Jeff Kvaal 41 Pi Sunyer 41 Matthew Emmens 41 ANALYST TAKE Barclays Capital 41 Theo Kitz 41 analyst Margaret Mager 41 Mark Bacurin 41 Allos Therapeutics Incorporated 41 Michael Vinciquerra 41 Domchek 41 AmTech 41 analyst Jeffrey Fidacaro 41 drug Enbrel 41 Helvea AG 41 Gert Zonneveld analyst 41 M. Kwas 41 Salmedix 41 RBC NYSE RY 41 Reiterates Buy rating 41 Piper Jaffray downgraded 41 Analyst Richard Withagen 41 Kelfer 41 Vishal Shreedhar 41 Kian Abouhossein 41 Adrienne Tennant 41 SG Cowen Securities 41 Doug Sipkin 41 analyst Mikir Shah 41 Perler 41 Sanjiv Wadhwani 41 analyst Srini Pajjuri 41 Vredenburgh 41 Matthew Fassler 41 Wedbush analyst 41 ThinkEquity 41 Domanskis 41 Roger Perlmutter 41 Schwab Soundview 41 Landesbank Rheinland Pfalz 41 strategist Graham Secker 41 Rabo Securities analyst 41 analyst Uche Orji 41 Suneet Kamath 41 Burdett Buckeridge Young 41 analyst Peter Misek 41 R. Badishkanian 41 Cai von Rumohr 41 analyst Hamed Khorsand 41 Julien Roch 41 Drew Fromkin President 41 Abouhossein 41 Andreas Willi 41 analyst Jeff Fidacaro 41 ThinkPanmure analyst 41 AstraZeneca AZN.ISE 41 Daniel Berenbaum 41 Ms. Lewent 41 WR Hambrecht reiterate 41 analyst Ajit Pai 41 Brean Murray 41 analyst Dorothy Lakner 41 ICON plc 41 Laura Conigliaro 41 analyst Les Funtleyder 41 Merck Finck analyst 41 Nadol 41 analyst Tal Liani 41 Unterberg Towbin 41 Ragen MacKenzie 41 analyst Randy Binner 41 Merck Januvia 41 analyst Mark Swartzberg 41 Tahira Afzal 41 DiTonno 41 Peer Perform rating 41 Hans Joachim Lohrisch 41 Kevin Ellich 41 Inc. NASDAQ EVVV 41 Kartsonas 41 Broker Panmure Gordon 41 told Outsourcing Pharma.com 41 FTN Equity Capital Markets 41 Douglas Harned 41 Avanir 41 Vitaxin 41 Phil Nalbone 41 Juhng 41 Cordaptive 41 Navigant Consulting Inc 41 Shoelson 41 Equinet AG 41 generic Lovenox 41 Bianco MD 41 Joe Osha 41 analyst Constance Maneaty 41 Amylin Byetta 41 analyst Harm Meijer 41 QLT CN 41 Cialis Cymbalta 41 ANALYST TAKE Jefferies 41 Celgene 41 Hapoalim Securities 41 Broadpoint.AmTech 41 IDEV 41 TNGN 41 Trusheim 41 James Kumpel 41 Glen Yeung 41 Clozel 41 Sector Perform rating 41 Suntrust Robinson 41 Muken 41 Patrice Milos 41 Panagiotis Spiliopoulos 41 Patricia Oey 41 Kimberly Greenberger 41 ANALYST TAKE Bear Stearns 41 Marc Cluzel 41 Andrew Obin 41 analyst Jeffrey Klinefelter 41 Fandetti 41 ThinkEquity Partners analyst 41 CorporateCommunications +#-#-#-# 41 Reiterates Outperform 41 analyst Michael Masdea 41 Ajit Pai 41 Arcalyst 41 Ciaran Callaghan 41 John R. Plachetka 41 Camvia 41 MD FACG 41 Stopeck 41 analyst Colin McGranahan 41 JP Morgan 40 Hamed Khorsand 40 Sal Tharani 40 fampridine SR 40 Amusa 40 Exanta 40 brokerage Cheuvreux 40 Preos 40 Ole Slorer 40 Ronan O'Caoimh CEO 40 Ph.D. XenoPort 40 Broadpoint.AmTech analyst 40 analyst Thilo Wrede 40 Donald Fandetti 40 Winkelmayer 40 Jonathan Ruykhaver 40 D. Hoselton 40 Neely JN Tamminga 40 Zavoico 40 Michael Blogg 40 Richard Schilsky 40 Nattel 40 PJ Juvekar 40 Grothey 40 Butchofsky 40 Robin Bienenstock 40 Bresalier 40 analyst Maher Yaghi 40 analyst Ann Duignan 40 Keeps Neutral 40 Jay Gelb 40 Schenosky 40 Antegren 40 Nemunaitis 40 Opko 40 Jeff Van Sinderen 40 Remi Barbier 40 Esther Kwon 40 AmTech Research 40 Symlin 40 Rutschow 40 Styponias 40 Staphos 40 Karnauskas 40 analyst Lori Appelbaum 40 analyst Romit Shah 40 Smotrich 40 Cihra 40 Pisetsky 40 OvaRex 40 Douglas Sipkin 40 William Tanona 40 Rob Cihra 40 Sandra McCullagh 40 Brock Vandervliet 40 Brent Thill 40 Ananda Baruah 40 Jeremy Sigee 40 Maintains Neutral 40 analyst Dan Wewer 40 Klude 40 Maintains Buy 40 Christine Farkas 40 Ursaner 40 Fusilev 40 Alexia Quadrani 40 CR Bard BCR 40 Stelios Papadopoulos 40 Roger Boissonneault 40 A. Viehbacher 40 analyst Richard Fetyko 40 Darusentan 40 ThinkEquity Partners 40 Co MRK 40 RenaMed 40 MD Geron 40 Johong 40 Randy Binner 40 ANALYST TAKE Merrill Lynch 40 Sensipar 40 SG Cowen 40 analyst Arnab Chanda 40 Piper Jaffray reiterates 40 Morgan Stanely 40 William Plovanic 40 Meredith Adler 40 Chris Brendler 40 Feltl & 40 Bergenstal 40 Michael Rehaut 40 Abate Shen 40 analyst Christopher Danely 40 DrugResearcher.com 40 Pepine 40 Sara Senatore 40 Emmens 40 Andrea Rachman 40 Gail Mifsud 40 analyst Katy Huberty 40 MyVax personalized immunotherapy 40 Leffell 40 Stifel Nicholaus 40 Witzke 40 @ FiercePharma 40 Leerink analyst 40 analyst Hussein Allidina 40 Sterne Agee analyst 40 Amgen denosumab 40 Duane Grubert 40 Piper Jaffray Cos 40 analyst Joseph Nadol 40 Keybanc Capital Markets 40 Nicholas Landekic 40 Kelly Luethje #-#-# 40 Broadpoint AmTech 40 Exane 40 Moazami 40 E Winningham 40 Analyst Cai von 40 Ramon Llamas IDC 40 Peter Appert 40 Blackmont Capital analyst 40 Chris Umiastowski 40 Durect Corp. 40 Maintains Neutral Rating 40 Galida 40 analyst Jeffrey Blaeser 40 Pathway Diagnostics 40 Seyrafi 40 analyst Colby Synesael 40 Sam Buttrick 40 Edward Ditmire analyst 40 Matt Nemer 40 Nesvold 40 Bleustein 40 Gerry Hennigan 40 Stifel Nicholas 40 Paul Averback 40 Richard Treagus 40 Piper Jaffray 40 analyst Safa Rashtchy 40 analyst Jeffrey Kvaal 40 Hans Mosesmann 40 Cristofanilli 40 Numis analyst 40 analyst Connie Maneaty 40 L. Enns 40 spokeswoman Lenore Gelb 40 analyst Alexander Peterc 40 analyst Edward Ditmire 40 Nicholas Aberle 40 Ton van Ooijen 40 PhD RPh 40 Melich